Traws Pharma, Inc. Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage
Traws Pharma, Inc. (TRAW) reported Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage of 25.00% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-28.
Discontinued › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage · last filed 2016-03-28
- Traws Pharma, Inc. defined contribution plan, employers matching contribution, annual vesting percentage for fiscal 2015 was 25.00%, a 0.00% change from fiscal 2014.
- Traws Pharma, Inc. defined contribution plan, employers matching contribution, annual vesting percentage for fiscal 2014 was 25.00%, a 0.00% change from fiscal 2013.
- Traws Pharma, Inc. defined contribution plan, employers matching contribution, annual vesting percentage for fiscal 2013 was 25.00%.
| Period end | Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage 12 month |
|---|---|
| 2015-12-31 | 25.00% 10-K · filed 2016-03-28 |
| 2014-12-31 | 25.00% 10-K · filed 2015-03-30 |
| 2013-12-31 | 25.00% 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |